Switching from concomitant therapy to tafluprost/timolol fixed combination
Kenji Inoue, Taku Kawashima, Seiki Katakura, Kyoko Shidara, Takayuki Fujimoto, Hiromi Kohmoto, Minako Shiokawa, Ryo Moriyama, Ryoko Okayama Inouye Eye Hospital, Tokyo, Japan Purpose: To evaluate the efficacy and safety of tafluprost/timolol fixed combination (TTFC). Study design: A prospective cli...
Main Authors: | Inoue K, Kawashima T, Katakura S, Shidara K, Fujimoto T, Kohmoto H, Shiokawa M, Moriyama R, Okayama R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-03-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/switching-from-concomitant-therapy-to-tafluprosttimolol-fixed-combinat-peer-reviewed-article-OPTH |
Similar Items
-
The 24-hour intraocular pressure control by tafluprost/timolol fixed combination after switching from the concomitant use of tafluprost and timolol gel-forming solution, in patients with primary open-angle glaucoma
by: Nakamoto K, et al.
Published: (2018-02-01) -
Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
by: Pillunat LE, et al.
Published: (2017-06-01) -
Green HPLC method with time programming for the determination of the co-formulated eye drops of tafluprost and timolol in their challengeable ratio
by: Walaa Nabil Abd-AlGhafar, et al.
Published: (2022-04-01) -
Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
by: Oddone F, et al.
Published: (2022-06-01) -
Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy
by: Ai-Wei Liu, et al.
Published: (2016-05-01)